Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: HUMSCs Combined With Col I to Third-Degree Burn Wound [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is currently recruiting to test the safety and potential efficacy of HUMSCs (human umbilical cord mesenchymal stem cells) combined wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Collagen Type I (collagen type I)
  • HUMSCs (human umbilical cord mesenchymal stem cells)

Snippet

Sponsor: The First Affiliated Hospital of Xinxiang Medical College | Conditions: Burn Wounds, Third-Degree Burn Wounds | Phase 1, Phase 2 | Status: RECRUITING